Application
Imidazolo-oxindole PKR inhibitor C16 has been used:to rescue fear memory deficits and restore long-term potentiation (LTP) impairment in miceto inhibit the strong induction of interferon stimulated genes (ISGs) after plasmid transfection in HeLa-S3 cellsto augment eukaryotic translation initiation factor 2 (eIF2) activity
Biochem/physiol Actions
Imidazolo-oxindole PKR inhibitor C16 is a selective inhibitor of RNA-dependent protein kinases (PKR, Eif2ak2). C16 is a first reported, potent and selective PKR inhibitor. Its inhibition effect on PKR is ATP-binding site directed. C16 specifically inhibits the apoptotic PKR/eIF2a signaling pathway without stimulating the proliferative mTOR/p70S6K signaling mechanism.
C16 exhibits a neuroprotective role in adult brain injuries.
Packaging
5, 25 mg in glass bottle
This product has met the following criteria to qualify for the following awards: